Literature DB >> 7284692

An analysis of functional antagonism and synergism.

D Mackay.   

Abstract

1 A method is described for deriving null equations for functional antagonism and synergism. These null equations relate together the concentrations of agonist required to produce equivalent states of a cell or tissue in the presence and in the absence of a functional interactant. 2 In one particular case the null equation leads to conclusions which are very similar to those reached by an earlier author who did not use the null method. However, the null equations give a clearer insight into the quantitative aspects of functional interaction. 3 It is concluded that the use of functional antagonism to estimate affinity constants and relative intrinsic efficacies of agonists has serious limitations. On the other hand, it may be possible to use the null equations, or similar principles, to test the validity of postulated mechanisms and sites of action of functional interactants.

Mesh:

Year:  1981        PMID: 7284692      PMCID: PMC2071862          DOI: 10.1111/j.1476-5381.1981.tb16781.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  9 in total

1.  A modification of receptor theory.

Authors:  R P STEPHENSON
Journal:  Br J Pharmacol Chemother       Date:  1956-12

2.  A theoretical basis of molecular pharmacology. III. Interaction of one or two compounds with two independent receptor systems.

Authors:  E J ARIENS; A M SIMONIS; J M VAN ROSSUM
Journal:  Arzneimittelforschung       Date:  1956-12

3.  On the use of functional antagonism to estimate dissociation constants for beta adrenergic receptor agonists in isolated guinea-pig trachea.

Authors:  C K Buckner; R K Saini
Journal:  J Pharmacol Exp Ther       Date:  1975-09       Impact factor: 4.030

4.  A new approach to the measurement and classification of forms of supersensitivity of autonomic effector responses.

Authors:  S Kalsner
Journal:  Br J Pharmacol       Date:  1974-07       Impact factor: 8.739

5.  On the analysis of pharmacological experiments in terms of an allosteric receptor model.

Authors:  C D Thron
Journal:  Mol Pharmacol       Date:  1973-01       Impact factor: 4.436

6.  The model of functional interaction. I. Development and first check of a new model of functional synergism and antagonism.

Authors:  F G van den Brink
Journal:  Eur J Pharmacol       Date:  1973-06       Impact factor: 4.432

7.  The model of functional interaction. II. Experimental verification of a new model: the antagonism of beta-adrenoceptor stimulants and other agonists.

Authors:  F G van den Brink
Journal:  Eur J Pharmacol       Date:  1973-06       Impact factor: 4.432

8.  A general analysis of the receptor-drug interaction.

Authors:  D Mackay
Journal:  Br J Pharmacol Chemother       Date:  1966-01

9.  Functional antagonism as a means of determining dissociation constants and relative efficacies of sympathomimetic amines in guinea-pig isolated atria.

Authors:  K J Broadley; C D Nicholson
Journal:  Br J Pharmacol       Date:  1979-07       Impact factor: 8.739

  9 in total
  18 in total

1.  A comparison of effects measured with isotonic and isometric recording: II. Concentration-effect curves for physiological antagonists.

Authors:  R B Barlow; S M Bond; C Grant; D S McQueen; Z Yaqoob
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

2.  Why patients with Alzheimer's disease may show increased sensitivity to tropicamide eye drops: role of locus coeruleus.

Authors:  R H Hou; E R Samuels; M Raisi; R W Langley; E Szabadi; C M Bradshaw
Journal:  Psychopharmacology (Berl)       Date:  2005-11-25       Impact factor: 4.530

3.  Analysis of competitive antagonism when this property occurs as part of a pharmacological resultant.

Authors:  J W Black; V P Gerskowitch; P Leff; N P Shankley
Journal:  Br J Pharmacol       Date:  1986-11       Impact factor: 8.739

4.  Affinities of full agonists for cardiac beta-adrenoceptors calculated by use of in vitro desensitization.

Authors:  M L Herepath; K J Broadley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-06       Impact factor: 3.000

5.  Mu and kappa opioid receptor modulation of 5-HT3 and NK-3 receptor-evoked release of acetylcholine from the guinea-pig ileum myenteric plexus.

Authors:  A J Fox; I K Morton
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-07       Impact factor: 3.000

6.  Quantification of the actions of agonists that simultaneously act on a particular type of receptor and have separate functional interactant properties.

Authors:  J Goodall; I E Hughes; D Mackay
Journal:  Br J Pharmacol       Date:  1986-07       Impact factor: 8.739

7.  Rho-kinase inhibition attenuates calcium-induced contraction in β-escin but not Triton X-100 permeabilized rabbit femoral artery.

Authors:  Lyndsay J Clelland; Brendan M Browne; Silvina M Alvarez; Amy S Miner; Paul H Ratz
Journal:  J Muscle Res Cell Motil       Date:  2011-06-25       Impact factor: 2.698

8.  Desensitization and functional antagonism by beta-adrenoceptor and muscarinic receptor agonists, respectively: a comparison with receptor alkylation for calculation of apparent agonist affinity.

Authors:  R M Eglen; W W Montgomery; R L Whiting
Journal:  Br J Pharmacol       Date:  1991-08       Impact factor: 8.739

9.  Different mechanisms of action of agents acting on beta-adrenoceptors in barium-stimulated and electrically-stimulated rat vas deferens.

Authors:  A Diaz-Toledo; A Jurkiewicz
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

10.  Interactions between responses mediated by activation of adenosine A2 receptors and alpha 1-adrenoceptors in the rabbit isolated aorta.

Authors:  H L Wiener; G P Thalody; S Maayani
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.